Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment

References

• Organisation WH. WHO coronavirus disease (COVID-19) dashboard. 2021.
   Google Scholar
• Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–1424.
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip M, NJM VDM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150.
   PubMed Web of Science ®Google Scholar
• Lax SF, Skok K, Zechner P, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020;173(5):350–361.
   PubMed Web of Science ®Google Scholar
• Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178–1191.
   PubMed Web of Science ®Google Scholar
• Siddiqi HK, Mehra MRCOVID-19. illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405–407.
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128.
   PubMed Web of Science ®Google Scholar
• White-Dzuro G, Gibson LE, Zazzeron L, et al. Multisystem effects of COVID-19: a concise review for practitioners. Postgrad Med. 2021;133(1):20–27.
   PubMed Web of Science ®Google Scholar
• Moores LK, Tritschler T, Brosnahan S, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019 CHEST guideline and expert panel report. Chest. 2020;158(3):1143–1163.
   PubMed Web of Science ®Google Scholar
• Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72–81.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-Art review. J Am Coll Cardiol. 2020;75(23):2950–2973.
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–1865.
   PubMed Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026.
   PubMed Web of Science ®Google Scholar
• Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York city health system. JAMA. 2020;324(8):799–801.
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098.
   PubMed Web of Science ®Google Scholar
• Giustozzi M, Vedovati MC, Agnelli G. Venous thromboembolism and COVID-19: mind the gap between clinical epidemiology and patient management. Eur J Intern Med. 2020;82:18–20.
   PubMed Web of Science ®Google Scholar
• Moll M, Zon RL, Sylvester KW, et al. VTE in ICU patients with COVID-19. Chest. 2020;158(5):2130–2135.
   PubMed Web of Science ®Google Scholar
• Jimenez D, Garcia-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2020.
   Web of Science ®Google Scholar
• Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142(2):184–186.
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489–500.
   PubMed Web of Science ®Google Scholar
• Boyd S, Martin-Loeches I. The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients. Ir J Med Sci. 2021. DOI:https://doi.org/10.1007/s11845-020-02503-0
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip M, NJM VDM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147.
   PubMed Web of Science ®Google Scholar
• Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77(2):198–209.
   PubMed Web of Science ®Google Scholar
• Lowenstein CJ, Solomon SD, Severe COVID-19. Is a microvascular disease. Circulation. 2020;142(17):1609–1611.
   PubMed Web of Science ®Google Scholar
• Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60.
   PubMed Web of Science ®Google Scholar
• Etkin Y, Conway AM, Silpe J, et al. Acute arterial thromboembolism in patients with COVID-19 in the New York city area. Ann Vasc Surg. 2021;70:290–294.
   PubMed Web of Science ®Google Scholar
• Bellosta R, Luzzani L, Natalini G, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72(6):1864–1872.
   PubMed Web of Science ®Google Scholar
• Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020;18(4):786–787.
   PubMed Web of Science ®Google Scholar
• Iba T, Levy JH, Levi M, et al. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–2109.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418.
   PubMed Web of Science ®Google Scholar
• Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018;16(2):231–241.
   PubMed Web of Science ®Google Scholar
• Grobler C, Maphumulo SC, Grobbelaar LM, et al. Covid-19: the rollercoaster of fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci. 2020;21(14):5168.
   PubMed Web of Science ®Google Scholar
• Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–1742.
   PubMed Web of Science ®Google Scholar
• Goshua G, Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e82.
   PubMed Web of Science ®Google Scholar
• Mortus JR, Manek SE, Brubaker LS, et al. Thromboelastographic results and hypercoagulability syndrome in patients with coronavirus disease 2019 who are critically Ill. JAMA Network Open. 2020;3(6):e2011192.
   PubMed Web of Science ®Google Scholar
• Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352–2371.
   PubMed Web of Science ®Google Scholar
• Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878–2887.
   PubMed Web of Science ®Google Scholar
• Li J, Liu Z, Wu G, et al. d-dimer as a prognostic indicator in critically Ill patients hospitalized with COVID-19 in Leishenshan hospital, Wuhan, China. Front Pharmacol. 2020;11:600592.
   PubMed Web of Science ®Google Scholar
• Battinelli EMCOVID-19. concerns aggregate around platelets. Blood. 2020;136(11):1221–1223.
   PubMed Web of Science ®Google Scholar
• Rampotas A, Pavord S. Platelet aggregates, a marker of severe COVID-19 disease. J Clin Pathol. 2020. DOI:https://doi.org/10.1136/jclinpath-2020-206933
   PubMed Web of Science ®Google Scholar
• Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317–1329.
   PubMed Web of Science ®Google Scholar
• Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1469–1472.
   PubMed Web of Science ®Google Scholar
• Bowles L, Platton S, Yartey N, et al. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med. 2020;383(3):288–290.
   PubMed Web of Science ®Google Scholar
• Harzallah I, Debliquis A, Drenou B. Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. 2020;18(8):2064–2065.
   PubMed Web of Science ®Google Scholar
• Giannakopoulos B, Passam F, Ioannou Y, et al. How we diagnose the antiphospholipid syndrome. Blood. 2009;113(5):985–994.
   PubMed Web of Science ®Google Scholar
• Devreese KMJ, Linskens EA, Benoit D, et al. Antiphospholipid antibodies in patients with COVID-19: a relevant observation? J Thromb Haemost. 2020;18(9):2191–2201.
   PubMed Web of Science ®Google Scholar
• Reyes Gil M, Barouqa M, Szymanski J, et al. Assessment of Lupus anticoagulant positivity in patients with coronavirus disease 2019 (COVID-19). JAMA Network Open. 2020;3(8):e2017539.
   PubMed Web of Science ®Google Scholar
• Mills K, Sobukonla T, Lee M, et al. DECODING COVID-19: a NOVEL ROLE OF ANTITHROMBIN DEFICIENCY IN THE NOVEL CORONAVIRUS. Chest. 2020;158(4):4.
   Web of Science ®Google Scholar
• Connors JM, Levy JH. Thrombo inflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559–1561.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15(7):e0235458.
   PubMed Web of Science ®Google Scholar
• Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021;113(1):45–57.
   PubMed Web of Science ®Google Scholar
• Rosovsky RP, Grodzin C, Channick R, et al. Diagnosis and treatment of pulmonary embolism during the coronavirus disease 2019 pandemic: a position paper from the national PERT consortium. Chest. 2020;158(6):2590–2601.
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324–1329.
   PubMed Web of Science ®Google Scholar
• Linkins LA, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39(Suppl 1):98–103.
   PubMed Web of Science ®Google Scholar
• Yao Y, Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8(1):49.
   PubMed Web of Science ®Google Scholar
• Flaczyk A, Rosovsky RP, Reed CT, et al. Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations. Crit Care. 2020;24(1):559.
   PubMed Web of Science ®Google Scholar
• Connors JM. 2021. ACTIV-IV COVID-19 outpatient thrombosis prevention trial.
   Google Scholar
• Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008;122(6):743–752.
   PubMed Web of Science ®Google Scholar
• Hippensteel JA, LaRiviere WB, Colbert JF, et al. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020;319(2):L211–L7.
   PubMed Web of Science ®Google Scholar
• Spiezia L, Boscolo A, Poletto F, et al. COVID-19-Related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020;120(6):998–1000.
   PubMed Web of Science ®Google Scholar
• Lin L, Lu L, Cao W, et al. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727–732.
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099.
   PubMed Web of Science ®Google Scholar
• Health NIo. Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients. 2021.
   Google Scholar
• Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021;5(3):872–888.
   PubMed Web of Science ®Google Scholar
• Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with coVID-19. J Am Coll Cardiol. 2020;76(16):1815–1826.
   PubMed Web of Science ®Google Scholar
• Wang L, Li H, Gu X, et al. Effect of Antiplatelet therapy on acute respiratory distress syndrome and mortality in critically Ill patients: a meta-Analysis. PLoS One. 2016;11(5):e0154754.
   PubMed Web of Science ®Google Scholar
• D’Souza R, Malhame I, Teshler L, et al. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand. 2020;99(9):1110–1120.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio JJ, Barroso-Aranda J. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: potential of pentoxifylline and dipyridamole. Med Hypotheses. 2020;143:110051.
   PubMed Web of Science ®Google Scholar
• Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, ICU admission, and in-hospital mortality in hospitalized patients with COVID-19. Anesth Analg. 2020.
   Web of Science ®Google Scholar
• Salah HM, Mehta JL. Meta-Analysis of the effect of aspirin on mortality in COVID-19. Am J Cardiol. 2021.
   Google Scholar
• Trial R. Aspirin to be investigated as a possible treatment for COVID-19 in the RECOVERY trial.
   Google Scholar
• Maurer LR, Luckhurst CM, Hamidi A, et al. A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically ill COVID-19 patients. J Crit Care. 2020;60:253–259.
   PubMed Web of Science ®Google Scholar
• Endres P, Rosovsky R, Zhao S, et al. Filter clotting with continuous renal replacement therapy in COVID-19. J Thromb Thrombolysis. 2020.
   PubMed Web of Science ®Google Scholar
• Barrett CD, Oren-Grinberg A, Chao E, et al. Rescue therapy for severe COVID-19-associated acute respiratory distress syndrome with tissue plasminogen activator: a case series. J Trauma Acute Care Surg. 2020;89(3):453–457.
   PubMed Web of Science ®Google Scholar
• Wang J, Hajizadeh N, Moore EE, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb Haemost. 2020;18(7):1752–1755.
   PubMed Web of Science ®Google Scholar
• Kabrhel C, Rosovsky R, Channick R, et al. A multidisciplinary pulmonary embolism response team: initial 30-Month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest. 2016;150(2):384–393.
   PubMed Web of Science ®Google Scholar
• Streng AS, Delnoij TSR, Mulder MMG, et al. Monitoring of unfractionated Heparin in severe COVID-19: an observational study of patients on CRRT and ECMO. TH Open. 2020;4(4):e365–e75.
   PubMedGoogle Scholar
• White D, MacDonald S, Bull T, et al. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020;50(2):287–291.
   PubMed Web of Science ®Google Scholar
• Trunfio M, Salvador E, Cabodi D, et al. Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. Thromb Res. 2020;196:432–434.
   PubMed Web of Science ®Google Scholar
• Zhou X, Cheng Z, Luo L, et al. Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis. Thromb Res. 2021;201:23–29.
   PubMed Web of Science ®Google Scholar
• Patell R, Bogue T, Koshy A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136(11):1342–1346.
   PubMed Web of Science ®Google Scholar
• Roberts LN, Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347–1350.
   PubMed Web of Science ®Google Scholar
• Hill JB, Garcia D, Crowther M, et al. Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study. Blood Adv. 2020;4(21):5373–5377.
   PubMed Web of Science ®Google Scholar
• Ortel T. 2021. COVID-19 thrombosis prevention trials: post-hospital thromboprophylaxis.
   Google Scholar